title: Immune checkpoint inhibition in malignant mesothelioma: Does it have a future?
authors.affiliation: Department of Oncology, Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States. Electronic address: mansfield.aaron@mayo.edu.
authors.forename: Aaron Scott
authors.initials: AS
authors.lastname: Mansfield
mesh_terms: D000074322:Antineoplastic Agents, Immunological / Q000494:pharmacology / Q000627:therapeutic use*; D014408:Biomarkers, Tumor; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism / Q000401:mortality; D008654:Mesothelioma / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism / Q000401:mortality; D000086002:Mesothelioma, Malignant; D058990:Molecular Targeted Therapy; D016896:Treatment Outcome
chemical_list: D000074322:Antineoplastic Agents, Immunological; D014408:Biomarkers, Tumor